Biotech News
Artivion Reports Third Quarter 2025 Financial Results
investors.artivion.com2026-05-06 14:57 EST
Third Quarter Highlights: Achieved revenue of $113.4 million in the third quarter of 2025 versus $95.8 million in the third quarter of 2024, an increase of 18% on a GAAP basis and 16% on a non-GAAP constant currency basis Net income was $6.5 million , or $0.13 per fully diluted share, and non-GAAP
